advanced search

RESPIRATORY

ROUNDTABLE: CAPSULE-BASED DRY POWDER INHALERS
ROUNDTABLE
Frédérique Bordes-Picard
Lonza
ROUNDTABLE: CAPSULE-BASED DRY POWDER INHALERS
Frédérique Bordes-Picard of Lonza, Marco Franza of Berry, Mirjam Kobler of Meggle, and Marco Laackmann of Harro Höfliger, discuss the accelerating development potential of capsule-based dry powder inhalers (DPIs) and the potential of these effective and efficient drug delivery devices in the modern drug delivery market.
TRANSFORMING DRUG DELIVERY WITH SYNERGISTIC WORKING
PULMONARY
Bas van Driel
DFE Pharma
TRANSFORMING DRUG DELIVERY WITH SYNERGISTIC WORKING
Bas van Driel discusses how expert collaborations can help develop a knowledge base to transform drug delivery and manufacturing. He shares how recent collaborative research projects involving lactose-based dry powder inhalation formulations, with and without magnesium stearate and lactose as an excipient in 3D tablet printing, have done just that.
SUCCESSFULLY BALANCING THE NEEDS OF THE PLANET WITH THE NEEDS OF THE PATIENT
SUSTAINABILITY
Julien Storz
Aptar Pharma
SUCCESSFULLY BALANCING THE NEEDS OF THE PLANET WITH THE NEEDS OF THE PATIENT
Christophe Marie, Taylor Price and Julien Storz chart the commitments and progress made to date by Aptar in achieving its sustainability targets. The authors also provide examples of integrated, circular economy initiatives undertaken by Aptar Pharma at a product solution level and comment on concrete commitments that can be made to further progress towards sustainability.
SIX INHALER SUSTAINABILITY MYTHS – AND WHY THEY MUST BE BUSTED
SUSTAINABILITY
Louise Righton
Kindeva
SIX INHALER SUSTAINABILITY MYTHS – AND WHY THEY MUST BE BUSTED
Louise Righton busts six sustainability myths about inhalers.
PLASMA TECHNOLOGY – THE FUTURE OF RESPIRATORY DEVICES
SUSTAINABILITY
Jacqueline Green
H&T Presspart
PLASMA TECHNOLOGY – THE FUTURE OF RESPIRATORY DEVICES
Jacqueline Green discusses how H&T Presspart’s plasma treatment process can provide a future-proof and sustainable solution for some of the issues associated with suspension formulations in the respiratory device industry.
EIGHT ESSENTIAL SUSTAINABILITY TERMS FOR THE MEDICAL DEVICE INDUSTRY
EXPERT VIEW
Kay Sinclair
EIGHT ESSENTIAL SUSTAINABILITY TERMS FOR THE MEDICAL DEVICE INDUSTRY
Kay Sinclair, Brennan Miles and Charlie Dean provide an overview of eight terms key to a common understanding in the ongoing, and crucial, discussion surrounding sustainability.
CONNECTED DEVICES CHALLENGE: HOW TO DEVELOP CONCEPT DEVICES WITH PEEK POLYMERS
CONNECTIVITY
Marcus Jarman-Smith
Victrex
CONNECTED DEVICES CHALLENGE: HOW TO DEVELOP CONCEPT DEVICES WITH PEEK POLYMERS
Marcus Jarman-Smith, Adam Salmen, John Devine, Ernst Hupkes and Dennis Freie discuss the value of PEEK, a high-performance polymer, in drug delivery device design, using two concept devices – an on-body patch pump and vaporiser inhaler.
MEANING-CENTRED PRODUCT DEVELOPMENT: THE KEY TO SUCCESSFUL CONNECTED DISEASE MANAGEMENT
CONNECTIVITY
Christina Philpott
MEANING-CENTRED PRODUCT DEVELOPMENT: THE KEY TO SUCCESSFUL CONNECTED DISEASE MANAGEMENT
Christina Philpott, Miles Hawley and Natasha French, discuss the future of connected disease management and the potential benefits for asthma treatment.
PUTTING THEIR HEALTH IN THEIR HANDS: ENHANCING RESPIRATORY PATIENT OUTCOMES THROUGH DIGITAL THERAPEUTICS
CONNECTIVITY
Adam Shain
Aptar Pharma
PUTTING THEIR HEALTH IN THEIR HANDS: ENHANCING RESPIRATORY PATIENT OUTCOMES THROUGH DIGITAL THERAPEUTICS
Adam Shain discusses the role digital therapeutics play in respiratory patient outcomes and looks at the potential for expansion into other therapy areas.
SPECIALTY LCP COMPOUNDS FOR ELECTRONICS INTEGRATION IN CONNECTED MEDICAL DEVICES
CONNECTIVITY
Dr Young Kim
Celanese
SPECIALTY LCP COMPOUNDS FOR ELECTRONICS INTEGRATION IN CONNECTED MEDICAL DEVICES
Young Kim, Don DeMello and Philip Wilson, discuss the benefits of recent advances in liquid crystal polymer for connected medical devices.
PRACTICAL INSIGHTS INTO LACTOSE-BASED DPI FORMULATIONS, WITH & WITHOUT MAGNESIUM STEARATE
RESPIRATORY
Harry Peters
DFE Pharma
PRACTICAL INSIGHTS INTO LACTOSE-BASED DPI FORMULATIONS, WITH & WITHOUT MAGNESIUM STEARATE
Partners DFE Pharma, Hosokawa Micron and Harro Höfliger describe their unique multidisciplinary study into lactose-based DPI formulations including magnesium stearate, whose findings will give generic players a head-start in the development process so that they can tap into this rapidly growing market. The three companies announce that they will be presenting the key insights from their research to interested parties during a joint webinar on the June 30th, 2020.
THE CRITICAL ROLE OF TRAINING IN THE USE OF NASAL RESCUE THERAPIES
NASAL
Tim McLeroy
Noble
THE CRITICAL ROLE OF TRAINING IN THE USE OF NASAL RESCUE THERAPIES
Tim McLeroy discusses the role of nasally administered rescue treatments in preventing deaths from opioid overdose or misuse – highlighting the importance of training  and treatment availability.
SPRAY CHARACTERISATION TESTING FOR ORALLY INHALED AND NASAL DRUG PRODUCTS
RESPIRATORY
Francois Billard
Recipharm
SPRAY CHARACTERISATION TESTING FOR ORALLY INHALED AND NASAL DRUG PRODUCTS
Francois Billard and Lei Mao look at measurement systems for spray pattern and plume geometry dispensed by orally inhaled and nasal drug products.
CHARACTERISATION OF LACTOSE POWDERS FOR DPI APPLICATIONS
PULMONARY
Dr Aurelien Neveu
Granutools
CHARACTERISATION OF LACTOSE POWDERS FOR DPI APPLICATIONS
Aurélien Neveu, Michael Crowley and Tony McGorisk discuss the characterisation of lactose powders for use as excipients in DPI formulations. The authors go on to discuss an analysis of six Kerry lactose powders using GranuTools technology.
HOW EVOLVING PATIENT NEEDS HAVE FUELLED THE DEVELOPMENT OF NASAL DRUG DELIVERY
NASAL
Dr Julie Suman
Next Breath
HOW EVOLVING PATIENT NEEDS HAVE FUELLED THE DEVELOPMENT OF NASAL DRUG DELIVERY
Julie Suman considers how the needs of the patient have driven advances in nasal drug delivery and looks at the latest developments and benefits of this method of drug delivery.
BIOCOMPATIBILITY OF MEDICINAL PRODUCT MEDICAL DEVICE COMBINATIONS FOR AIRWAY DELIVERY
EXPERT VIEW
Mark Turner
BIOCOMPATIBILITY OF MEDICINAL PRODUCT MEDICAL DEVICE COMBINATIONS FOR AIRWAY DELIVERY
Mark Turner discusses biocompatibility testing for inhaled medical products, with particular reference to ISO 18562, and what Medical Engineering Technologies has learned from three years of breathing component biocompatibility testing.
INTEGRATED TURNKEY SOLUTIONS: KEY TO SUCCESSFUL NASAL COMBINATION PRODUCT DEVELOPMENT
RESPIRATORY
Alain Regard
Nemera
INTEGRATED TURNKEY SOLUTIONS: KEY TO SUCCESSFUL NASAL COMBINATION PRODUCT DEVELOPMENT
Alain Regard, Audrey Chandra and Pascale Farjas discuss the use of the nasal route for locally and systemic-acting drug treatments.
NASAL DELIVERY: AN OPPORTUNITY FOR SIGNIFICANT IMPROVEMENTS IN PATIENT CARE
EXPERT VIEW
Dr Stuart Madden
NASAL DELIVERY: AN OPPORTUNITY FOR SIGNIFICANT IMPROVEMENTS IN PATIENT CARE
Stuart Madden discusses the advantages of the nasal route of administration for the systemic delivery of therapeutics.
FORMULATION OPTIONS IN NASAL DRUG DELIVERY
EXPERT VIEW
Dr Richard Johnson
FORMULATION OPTIONS IN NASAL DRUG DELIVERY
Richard Johnson discusses the advantages of nasal delivery and why there is growing interest in this route of administration, as well as considering some of the challenges that may arise during the development of nasal formulations for use in the clinic, and the regulatory and testing requirements associated with them.
ASSESSING THE NASAL DRUG DELIVERY LANDSCAPE
NASAL
Dr Jon Volmer
MedPharm
ASSESSING THE NASAL DRUG DELIVERY LANDSCAPE
Jon Volmer, Jon Lenn and Professor Marc Brown discuss the role of reconstituted nasal epithelium in intranasal drug delivery.
SPRAY CHARACTERISATION TESTING
NASAL
Ann Flodin
Recipharm
SPRAY CHARACTERISATION TESTING
Ann Flodin introduces the company’s SprayVIEW® measurement and automated actuation stations for the development and quality control of container closures and finished products.
TOP FIVE DRUG DELIVERY TRENDS FOR 2021
EXPERT VIEW
Tom Oakley
TOP FIVE DRUG DELIVERY TRENDS FOR 2021
Tom Oakley provides an overview of the top five trends to expect in drug delivery in 2021.
INTRODUCING ISOSORBIDE: A SUSTAINABLE, SAFE, HIGH-PERFORMANCE, PLANT-BASED FEEDSTOCK FOR PACKAGING
SUSTAINABILITY
Jiae Kim
Roquette
INTRODUCING ISOSORBIDE: A SUSTAINABLE, SAFE, HIGH-PERFORMANCE, PLANT-BASED FEEDSTOCK FOR PACKAGING
Jiae Kim introduces isosorbide, a plant starch-derived diol made from renewable feedstock that has wide ranging applications across polymer materials for a variety of industries.
RS01X – BERRY GLOBAL HEALTHCARE’S SINGLE-DOSE DPI GOES DIGITAL WITH AMIKO’S RESPIRO
CONNECTIVITY
Mauro Citterio
RS01X – BERRY GLOBAL HEALTHCARE’S SINGLE-DOSE DPI GOES DIGITAL WITH AMIKO’S RESPIRO
Mauro Citterio, Director, Marco Franza and Martijn Grinovero discuss Berry and Amiko’s partnership to develop the RS01X connected single-dose dry powder inhaler, based on Berry’s commercialised RS01 inhaler and Amiko’s Respiro digital health platform.
Top